Global Oncology Small Molecule Drugs Market Insights, Forecast to 2028

  • Report ID:237216
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 127
                              
Oncology Small Molecule Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oncology Small Molecule Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Chemotherapy Drugs Immunomodulating Drugs Targeted Therapy Drugs Hormonal Therapy Other Segment by Application Blood Cancer Breast Cancer Gastrointestinal Cancer Prostate Cancer Lung Cancer Other By Company Roche Novartis Pfizer Celgene Bristol-Myers Squibb Amgen Johnson & Johnson AbbVie Sanofi Takeda Eli Lilly Bayer AstraZeneca Astellas Merck Biogen Idec Eisai Teva Otsuka Ipsen Gilead Sciences Exelixis By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Chemotherapy Drugs 1.2.3 Immunomodulating Drugs 1.2.4 Targeted Therapy Drugs 1.2.5 Hormonal Therapy 1.2.6 Other 1.3 Market by Application 1.3.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Blood Cancer 1.3.3 Breast Cancer 1.3.4 Gastrointestinal Cancer 1.3.5 Prostate Cancer 1.3.6 Lung Cancer 1.3.7 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oncology Small Molecule Drugs Market Perspective (2017-2028) 2.2 Oncology Small Molecule Drugs Growth Trends by Region 2.2.1 Oncology Small Molecule Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Oncology Small Molecule Drugs Historic Market Size by Region (2017-2022) 2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028) 2.3 Oncology Small Molecule Drugs Market Dynamics 2.3.1 Oncology Small Molecule Drugs Industry Trends 2.3.2 Oncology Small Molecule Drugs Market Drivers 2.3.3 Oncology Small Molecule Drugs Market Challenges 2.3.4 Oncology Small Molecule Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oncology Small Molecule Drugs Players by Revenue 3.1.1 Global Top Oncology Small Molecule Drugs Players by Revenue (2017-2022) 3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Oncology Small Molecule Drugs Revenue 3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio 3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2021 3.5 Oncology Small Molecule Drugs Key Players Head office and Area Served 3.6 Key Players Oncology Small Molecule Drugs Product Solution and Service 3.7 Date of Enter into Oncology Small Molecule Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Small Molecule Drugs Breakdown Data by Type 4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2017-2022) 4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028) 5 Oncology Small Molecule Drugs Breakdown Data by Application 5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2017-2022) 5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Oncology Small Molecule Drugs Market Size (2017-2028) 6.2 North America Oncology Small Molecule Drugs Market Size by Type 6.2.1 North America Oncology Small Molecule Drugs Market Size by Type (2017-2022) 6.2.2 North America Oncology Small Molecule Drugs Market Size by Type (2023-2028) 6.2.3 North America Oncology Small Molecule Drugs Market Share by Type (2017-2028) 6.3 North America Oncology Small Molecule Drugs Market Size by Application 6.3.1 North America Oncology Small Molecule Drugs Market Size by Application (2017-2022) 6.3.2 North America Oncology Small Molecule Drugs Market Size by Application (2023-2028) 6.3.3 North America Oncology Small Molecule Drugs Market Share by Application (2017-2028) 6.4 North America Oncology Small Molecule Drugs Market Size by Country 6.4.1 North America Oncology Small Molecule Drugs Market Size by Country (2017-2022) 6.4.2 North America Oncology Small Molecule Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Oncology Small Molecule Drugs Market Size (2017-2028) 7.2 Europe Oncology Small Molecule Drugs Market Size by Type 7.2.1 Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022) 7.2.2 Europe Oncology Small Molecule Drugs Market Size by Type (2023-2028) 7.2.3 Europe Oncology Small Molecule Drugs Market Share by Type (2017-2028) 7.3 Europe Oncology Small Molecule Drugs Market Size by Application 7.3.1 Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022) 7.3.2 Europe Oncology Small Molecule Drugs Market Size by Application (2023-2028) 7.3.3 Europe Oncology Small Molecule Drugs Market Share by Application (2017-2028) 7.4 Europe Oncology Small Molecule Drugs Market Size by Country 7.4.1 Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022) 7.4.2 Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Oncology Small Molecule Drugs Market Size (2017-2028) 8.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type 8.2.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Oncology Small Molecule Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application 8.3.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Oncology Small Molecule Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region 8.4.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Oncology Small Molecule Drugs Market Size (2017-2028) 9.2 Latin America Oncology Small Molecule Drugs Market Size by Type 9.2.1 Latin America Oncology Small Molecule Drugs Market Size by Type (2017-2022) 9.2.2 Latin America Oncology Small Molecule Drugs Market Size by Type (2023-2028) 9.2.3 Latin America Oncology Small Molecule Drugs Market Share by Type (2017-2028) 9.3 Latin America Oncology Small Molecule Drugs Market Size by Application 9.3.1 Latin America Oncology Small Molecule Drugs Market Size by Application (2017-2022) 9.3.2 Latin America Oncology Small Molecule Drugs Market Size by Application (2023-2028) 9.3.3 Latin America Oncology Small Molecule Drugs Market Share by Application (2017-2028) 9.4 Latin America Oncology Small Molecule Drugs Market Size by Country 9.4.1 Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022) 9.4.2 Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oncology Small Molecule Drugs Market Size (2017-2028) 10.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type 10.2.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Oncology Small Molecule Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application 10.3.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Oncology Small Molecule Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country 10.4.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Oncology Small Molecule Drugs Introduction 11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.1.5 Roche Recent Developments 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Oncology Small Molecule Drugs Introduction 11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.2.5 Novartis Recent Developments 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Oncology Small Molecule Drugs Introduction 11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.3.5 Pfizer Recent Developments 11.4 Celgene 11.4.1 Celgene Company Details 11.4.2 Celgene Business Overview 11.4.3 Celgene Oncology Small Molecule Drugs Introduction 11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.4.5 Celgene Recent Developments 11.5 Bristol-Myers Squibb 11.5.1 Bristol-Myers Squibb Company Details 11.5.2 Bristol-Myers Squibb Business Overview 11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction 11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.5.5 Bristol-Myers Squibb Recent Developments 11.6 Amgen 11.6.1 Amgen Company Details 11.6.2 Amgen Business Overview 11.6.3 Amgen Oncology Small Molecule Drugs Introduction 11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.6.5 Amgen Recent Developments 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction 11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.7.5 Johnson & Johnson Recent Developments 11.8 AbbVie 11.8.1 AbbVie Company Details 11.8.2 AbbVie Business Overview 11.8.3 AbbVie Oncology Small Molecule Drugs Introduction 11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.8.5 AbbVie Recent Developments 11.9 Sanofi 11.9.1 Sanofi Company Details 11.9.2 Sanofi Business Overview 11.9.3 Sanofi Oncology Small Molecule Drugs Introduction 11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.9.5 Sanofi Recent Developments 11.10 Takeda 11.10.1 Takeda Company Details 11.10.2 Takeda Business Overview 11.10.3 Takeda Oncology Small Molecule Drugs Introduction 11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.10.5 Takeda Recent Developments 11.11 Eli Lilly 11.11.1 Eli Lilly Company Details 11.11.2 Eli Lilly Business Overview 11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction 11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.11.5 Eli Lilly Recent Developments 11.12 Bayer 11.12.1 Bayer Company Details 11.12.2 Bayer Business Overview 11.12.3 Bayer Oncology Small Molecule Drugs Introduction 11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.12.5 Bayer Recent Developments 11.13 AstraZeneca 11.13.1 AstraZeneca Company Details 11.13.2 AstraZeneca Business Overview 11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction 11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.13.5 AstraZeneca Recent Developments 11.14 Astellas 11.14.1 Astellas Company Details 11.14.2 Astellas Business Overview 11.14.3 Astellas Oncology Small Molecule Drugs Introduction 11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.14.5 Astellas Recent Developments 11.15 Merck 11.15.1 Merck Company Details 11.15.2 Merck Business Overview 11.15.3 Merck Oncology Small Molecule Drugs Introduction 11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.15.5 Merck Recent Developments 11.16 Biogen Idec 11.16.1 Biogen Idec Company Details 11.16.2 Biogen Idec Business Overview 11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction 11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.16.5 Biogen Idec Recent Developments 11.17 Eisai 11.17.1 Eisai Company Details 11.17.2 Eisai Business Overview 11.17.3 Eisai Oncology Small Molecule Drugs Introduction 11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.17.5 Eisai Recent Developments 11.18 Teva 11.18.1 Teva Company Details 11.18.2 Teva Business Overview 11.18.3 Teva Oncology Small Molecule Drugs Introduction 11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.18.5 Teva Recent Developments 11.19 Otsuka 11.19.1 Otsuka Company Details 11.19.2 Otsuka Business Overview 11.19.3 Otsuka Oncology Small Molecule Drugs Introduction 11.19.4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.19.5 Otsuka Recent Developments 11.20 Ipsen 11.20.1 Ipsen Company Details 11.20.2 Ipsen Business Overview 11.20.3 Ipsen Oncology Small Molecule Drugs Introduction 11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.20.5 Ipsen Recent Developments 11.21 Gilead Sciences 11.21.1 Gilead Sciences Company Details 11.21.2 Gilead Sciences Business Overview 11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction 11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.21.5 Gilead Sciences Recent Developments 11.22 Exelixis 11.22.1 Exelixis Company Details 11.22.2 Exelixis Business Overview 11.22.3 Exelixis Oncology Small Molecule Drugs Introduction 11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022) 11.22.5 Exelixis Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Chemotherapy Drugs Table 3. Key Players of Immunomodulating Drugs Table 4. Key Players of Targeted Therapy Drugs Table 5. Key Players of Hormonal Therapy Table 6. Key Players of Other Table 7. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Oncology Small Molecule Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Oncology Small Molecule Drugs Market Share by Region (2017-2022) Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Oncology Small Molecule Drugs Market Share by Region (2023-2028) Table 13. Oncology Small Molecule Drugs Market Trends Table 14. Oncology Small Molecule Drugs Market Drivers Table 15. Oncology Small Molecule Drugs Market Challenges Table 16. Oncology Small Molecule Drugs Market Restraints Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Oncology Small Molecule Drugs Revenue Share by Players (2017-2022) Table 19. Global Top Oncology Small Molecule Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021) Table 20. Ranking of Global Top Oncology Small Molecule Drugs Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Oncology Small Molecule Drugs Product Solution and Service Table 24. Date of Enter into Oncology Small Molecule Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2017-2022) Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2023-2028) Table 30. Global Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Oncology Small Molecule Drugs Revenue Share by Application (2017-2022) Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Oncology Small Molecule Drugs Revenue Share by Application (2023-2028) Table 34. North America Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million) Table 35. North America Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million) Table 36. North America Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million) Table 37. North America Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million) Table 38. North America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million) Table 41. Europe Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million) Table 42. Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million) Table 43. Europe Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million) Table 44. Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million) Table 45. Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million) Table 46. Asia Pacific Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Oncology Small Molecule Drugs Market Size by Region (2023-2028) & (US$ Million) Table 52. Latin America Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million) Table 53. Latin America Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million) Table 54. Latin America Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million) Table 55. Latin America Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million) Table 56. Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million) Table 57. Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million) Table 64. Roche Company Details Table 65. Roche Business Overview Table 66. Roche Oncology Small Molecule Drugs Product Table 67. Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 68. Roche Recent Developments Table 69. Novartis Company Details Table 70. Novartis Business Overview Table 71. Novartis Oncology Small Molecule Drugs Product Table 72. Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 73. Novartis Recent Developments Table 74. Pfizer Company Details Table 75. Pfizer Business Overview Table 76. Pfizer Oncology Small Molecule Drugs Product Table 77. Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 78. Pfizer Recent Developments Table 79. Celgene Company Details Table 80. Celgene Business Overview Table 81. Celgene Oncology Small Molecule Drugs Product Table 82. Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 83. Celgene Recent Developments Table 84. Bristol-Myers Squibb Company Details Table 85. Bristol-Myers Squibb Business Overview Table 86. Bristol-Myers Squibb Oncology Small Molecule Drugs Product Table 87. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 88. Bristol-Myers Squibb Recent Developments Table 89. Amgen Company Details Table 90. Amgen Business Overview Table 91. Amgen Oncology Small Molecule Drugs Product Table 92. Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 93. Amgen Recent Developments Table 94. Johnson & Johnson Company Details Table 95. Johnson & Johnson Business Overview Table 96. Johnson & Johnson Oncology Small Molecule Drugs Product Table 97. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 98. Johnson & Johnson Recent Developments Table 99. AbbVie Company Details Table 100. AbbVie Business Overview Table 101. AbbVie Oncology Small Molecule Drugs Product Table 102. AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 103. AbbVie Recent Developments Table 104. Sanofi Company Details Table 105. Sanofi Business Overview Table 106. Sanofi Oncology Small Molecule Drugs Product Table 107. Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 108. Sanofi Recent Developments Table 109. Takeda Company Details Table 110. Takeda Business Overview Table 111. Takeda Oncology Small Molecule Drugs Product Table 112. Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 113. Takeda Recent Developments Table 114. Eli Lilly Company Details Table 115. Eli Lilly Business Overview Table 116. Eli Lilly Oncology Small Molecule Drugs Product Table 117. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 118. Eli Lilly Recent Developments Table 119. Bayer Company Details Table 120. Bayer Business Overview Table 121. Bayer Oncology Small Molecule Drugs Product Table 122. Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 123. Bayer Recent Developments Table 124. AstraZeneca Company Details Table 125. AstraZeneca Business Overview Table 126. AstraZeneca Oncology Small Molecule Drugs Product Table 127. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 128. AstraZeneca Recent Developments Table 129. Astellas Company Details Table 130. Astellas Business Overview Table 131. Astellas Oncology Small Molecule Drugs Product Table 132. Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 133. Astellas Recent Developments Table 134. Merck Company Details Table 135. Merck Business Overview Table 136. Merck Oncology Small Molecule Drugs Product Table 137. Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 138. Merck Recent Developments Table 139. Biogen Idec Company Details Table 140. Biogen Idec Business Overview Table 141. Biogen Idec Oncology Small Molecule Drugs Product Table 142. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 143. Biogen Idec Recent Developments Table 144. Eisai Company Details Table 145. Eisai Business Overview Table 146. Eisai Oncology Small Molecule Drugs Product Table 147. Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 148. Eisai Recent Developments Table 149. Teva Company Details Table 150. Teva Business Overview Table 151. Teva Oncology Small Molecule Drugs Product Table 152. Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 153. Teva Recent Developments Table 154. Otsuka Company Details Table 155. Otsuka Business Overview Table 156. Otsuka Oncology Small Molecule Drugs Product Table 157. Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 158. Otsuka Recent Developments Table 159. Ipsen Company Details Table 160. Ipsen Business Overview Table 161. Ipsen Oncology Small Molecule Drugs Product Table 162. Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 163. Ipsen Recent Developments Table 164. Gilead Sciences Company Details Table 165. Gilead Sciences Business Overview Table 166. Gilead Sciences Oncology Small Molecule Drugs Product Table 167. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 168. Gilead Sciences Recent Developments Table 169. Exelixis Company Details Table 170. Exelixis Business Overview Table 171. Exelixis Oncology Small Molecule Drugs Product Table 172. Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million) Table 173. Exelixis Recent Developments Table 174. Research Programs/Design for This Report Table 175. Key Data Information from Secondary Sources Table 176. Key Data Information from Primary Sources List of Figures Figure 1. Global Oncology Small Molecule Drugs Market Share by Type: 2021 VS 2028 Figure 2. Chemotherapy Drugs Features Figure 3. Immunomodulating Drugs Features Figure 4. Targeted Therapy Drugs Features Figure 5. Hormonal Therapy Features Figure 6. Other Features Figure 7. Global Oncology Small Molecule Drugs Market Share by Application: 2021 VS 2028 Figure 8. Blood Cancer Case Studies Figure 9. Breast Cancer Case Studies Figure 10. Gastrointestinal Cancer Case Studies Figure 11. Prostate Cancer Case Studies Figure 12. Lung Cancer Case Studies Figure 13. Other Case Studies Figure 14. Oncology Small Molecule Drugs Report Years Considered Figure 15. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 16. Global Oncology Small Molecule Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Oncology Small Molecule Drugs Market Share by Region: 2021 VS 2028 Figure 18. Global Oncology Small Molecule Drugs Market Share by Players in 2021 Figure 19. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021) Figure 20. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2021 Figure 21. North America Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 22. North America Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028) Figure 23. North America Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028) Figure 24. North America Oncology Small Molecule Drugs Market Size Share by Country (2017-2028) Figure 25. United States Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Europe Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 28. Europe Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028) Figure 29. Europe Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028) Figure 30. Europe Oncology Small Molecule Drugs Market Size Share by Country (2017-2028) Figure 31. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. France Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Nordic Countries Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 38. Asia Pacific Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028) Figure 39. Asia Pacific Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028) Figure 40. Asia Pacific Oncology Small Molecule Drugs Market Size Share by Region (2017-2028) Figure 41. China Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. India Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 47. Latin America Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 48. Latin America Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028) Figure 49. Latin America Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028) Figure 50. Latin America Oncology Small Molecule Drugs Market Size Share by Country (2017-2028) Figure 51. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 54. Middle East and Africa Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028) Figure 55. Middle East and Africa Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028) Figure 56. Middle East and Africa Oncology Small Molecule Drugs Market Size Share by Country (2017-2028) Figure 57. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. UAE Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 60. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 61. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 62. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 63. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 65. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 66. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 67. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 68. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 69. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 70. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 71. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 72. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 73. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 74. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 75. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 76. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 77. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 78. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 79. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 80. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 81. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022) Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.